Advertisement

Understanding why resistant bacteria are associated with higher mortality in ICU patients

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Fig. 1

References

  1. 1.

    Vincent J-L, Rello J, Marshall J et al (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–2329

  2. 2.

    Nseir S, Di Pompeo C, Soubrier S et al (2005) First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 33:283–289

  3. 3.

    Martin-Loeches I, Deja M, Koulenti D et al (2013) Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 39:672–681

  4. 4.

    Bassetti M, De Waele JJ, Eggimann P et al (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41:776–795

  5. 5.

    Vardakas KZ, Rafailidis PI, Konstantelias AA, Falagas ME (2013) Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? J Infect 66:401–414

  6. 6.

    Zilberberg MD, Shorr AF (2011) Ventilator-associated pneumonia as a model for approaching cost-effectiveness and infection prevention in the ICU. Curr Opin Infect Dis 24:385–389

  7. 7.

    Tabah A, Koulenti D, Laupland K et al (2012) Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 38:1930–1945

  8. 8.

    Schwaber MJ, Carmeli Y (2007) Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60:913–920

  9. 9.

    Garnacho-Montero J, Dimopoulos G, Poulakou G et al (2015) Task force on management and prevention of Acinetobacter baumannii infections in the ICU. Intensive Care Med 41:2057–2075

  10. 10.

    Paul M, Kariv G, Goldberg E et al (2010) Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 65:2658–2665

  11. 11.

    Combes A, Luyt C-E, Fagon J-Y et al (2004) Impact of Methicillin Resistance on Outcome of Staphylococcus aureus Ventilator-associated Pneumonia. Am J Respir Crit Care Med 170:786–792

  12. 12.

    Spapen H, Jacobs R, Van Gorp V et al (2011) Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care 1:14

  13. 13.

    Ruppé É, Woerther P-L, Barbier F (2015) Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care 5:61

  14. 14.

    Lisboa T, Diaz E, Sa-Borges M et al (2008) The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia. Chest 134:1208–1216

  15. 15.

    Zahar JR, Garrouste-Orgeas M, Vesin A et al (2013) Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events. Intensive Care Med 39:2153–2160

  16. 16.

    Sawa T, Shimizu M, Moriyama K, Wiener-Kronish JP (2014) Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review. Crit Care 18:668

Download references

Author information

Correspondence to Saad Nseir.

Ethics declarations

Conflicts of interest

FB: MSD (advisory board), Pfizer (conference invitation), Novartis (speaker fees); TL: none; SN: Bayer (advisory board).

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Barbier, F., Lisboa, T. & Nseir, S. Understanding why resistant bacteria are associated with higher mortality in ICU patients. Intensive Care Med 42, 2066–2069 (2016). https://doi.org/10.1007/s00134-015-4138-x

Download citation

Keywords

  • Colistin
  • Tigecyclin
  • Acinetobacter Baumannii
  • Augmented Renal Clearance
  • Alveolar Epithelial Injury